Steady-state energy balance in animal models of obesity and weight loss

References

• WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Paper presented at: The World Health Organization; 1997 June 3–5; Geneva, Switzerland. Publication WHO/NUT/NCD/98.1.
   Google Scholar
• Danaei G, Finucane MM, Lu Y, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating G. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.
   PubMed Web of Science ®Google Scholar
• Burton BT, Foster WR. Health implications of obesity: an NIH Consensus Development Conference. J Am Diet Assoc. 1985;85:1117–1121.
   PubMedGoogle Scholar
• Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88. doi: 10.1186/1471-2458-9-88.
   PubMed Web of Science ®Google Scholar
• Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med. 2013;159:ITC3-1-ITC3-15; quiz ITC3-6.
   Web of Science ®Google Scholar
• Colquitt J, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009:CD003641. doi: 10.1002/14651858.CD003641.
   PubMed Web of Science ®Google Scholar
• Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013;22:f5934. doi: 10.1136/bmj.f5934.
   Web of Science ®Google Scholar
• Carvajal R, Wadden TA, Tsai AG, et al. Managing obesity in primary care practice: a narrative review. Ann N Y Acad Sci. 2013;1281:191–206.
   PubMed Web of Science ®Google Scholar
• Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014;311:74–86.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Tschop MH, Wilding JP. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5:621–626.
   PubMed Web of Science ®Google Scholar
• Arch JR. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:225–240.
   PubMed Web of Science ®Google Scholar
• Mund RA, Frishman WH. Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humans. Cardiol Rev. 2013;21:265–269.
   PubMed Web of Science ®Google Scholar
• Manore MM, Brown K, Houtkooper L, et al. Energy balance at a crossroads: translating the science into action. Med Sci Sports Exerc. 2014;46:1466–1473.
   PubMed Web of Science ®Google Scholar
• Gautron L, Elmquist JK, Williams KW. Neural control of energy balance: translating circuits to therapies. Cell. 2015;161:133–145.
   PubMed Web of Science ®Google Scholar
• Hill JO, Wyatt HR, Peters JC. Energy balance and obesity. Circulation. 2012;126:126–132.
   PubMed Web of Science ®Google Scholar
• Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27:750–761.
   PubMed Web of Science ®Google Scholar
• Furnes MW, Zhao CM, Chen D. Development of obesity is associated with increased calories per meal rather than per day. A study of high-fat diet-induced obesity in young rats. Obes Surg. 2009;19:1430–1438.
   PubMed Web of Science ®Google Scholar
• la Fleur SE, Luijendijk MC, van der Zwaal EM, et al. The snacking rat as model of human obesity: effects of a free-choice high-fat high-sugar diet on meal patterns. Int J Obes (Lond). 2014;38:643–649.
   PubMed Web of Science ®Google Scholar
• Archer ZA, Rayner DV, Duncan JS, et al. Introduction of a high-energy diet acutely up-regulates hypothalamic cocaine and amphetamine-regulated transcript, Mc4R and brown adipose tissue uncoupling protein-1 gene expression in male Sprague–Dawley rats. J Neuroendocrinol. 2005;17:10–17.
   PubMed Web of Science ®Google Scholar
• Archer ZA, Rayner DV, Mercer JG. Hypothalamic gene expression is altered in underweight but obese juvenile male Sprague–Dawley rats fed a high-energy diet. J Nutr. 2004;134:1369–1374.
   PubMed Web of Science ®Google Scholar
• Briggs DI, Enriori PJ, Lemus MB, et al. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology. 2010;151:4745–4755.
   PubMed Web of Science ®Google Scholar
• Archer ZA, Rayner DV, Barrett P, et al. Hypothalamic energy balance gene responses in the Sprague–Dawley rat to supplementation of high-energy diet with liquid ensure and subsequent transfer to chow. J Neuroendocrinol. 2005;17:711–719.
   PubMed Web of Science ®Google Scholar
• Furnes M, Tømmerås K, Arum C-J, et al. Gastric bypass surgery causes body weight loss without reducing food intake in rats. Obes Surg. 2008;18:415–422.
   PubMed Web of Science ®Google Scholar
• Furnes MW, Stenstrom B, Tommeras K, et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res. 2008;40:279–288.
   PubMed Web of Science ®Google Scholar
• Kodama Y, Johannessen H, Furnes MW, et al. Mechanistic comparison between gastric bypass vs. duodenal switch with sleeve gastrectomy in rat models. PLoS One 2013;8:e72896. doi: 10.1371/journal.pone.0072896.
   PubMed Web of Science ®Google Scholar
• Bueter M, Lowenstein C, Olbers T, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology. 2010;138:1845–1853.
   PubMed Web of Science ®Google Scholar
• Bueter M, le Roux CW. Gastrointestinal hormones, energy balance and bariatric surgery. Int J Obes. 2011;35:S35–S39.
   Web of Science ®Google Scholar
• Xu Y, Ramos EJ, Middleton F, et al. Gene expression profiles post Roux-en-Y gastric bypass. Surgery. 2004;136:246–252.
   PubMed Web of Science ®Google Scholar
• Yamada M, Miyakawa T, Duttaroy A, et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 2001;410:207–212.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature. 2000;404:661–671.
   PubMed Web of Science ®Google Scholar
• Gautam D, Gavrilova O, Jeon J, et al. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab. 2006;4:363–375.
   PubMed Web of Science ®Google Scholar
• Matsui M, Motomura D, Karasawa H, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A. 2000;97:9579–9584.
   PubMed Web of Science ®Google Scholar
• Ramos-Jimenez A, Hernandez-Torres RP, Torres-Duran PV, et al. The respiratory exchange ratio is associated with fitness indicators both in trained and untrained men: a possible application for people with reduced exercise tolerance. Clin Med Circ Respir Pulm Med. 2008;2:1–9.
   PubMedGoogle Scholar
• Kindel T, Lomelin D, McBride C, et al. The time to weight-loss steady state after gastric bypass predicts weight-loss success. Obes Surg. 2016;26:327–331.
   PubMed Web of Science ®Google Scholar
• Luo N, Marcelin G, Liu SM, et al. Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency. Endocrinology. 2011;152:883–889.
   PubMed Web of Science ®Google Scholar
• Maresca A, Supuran CT. Muscarinic acetylcholine receptors as therapeutic targets for obesity. Expert Opin Ther Targets. 2008;12:1167–1175.
   PubMed Web of Science ®Google Scholar
• Chugh PK, Sharma S. Recent advances in the pathophysiology and pharmacological treatment of obesity. J Clin Pharm Ther. 2012;37:525–535.
   PubMed Web of Science ®Google Scholar
• Amorim BS, Ueta CB, Freitas BC, et al. A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol. 2009;203:291–299.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Kim DW, Jo EJ, et al. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes. 2009;58:965–974.
   PubMed Web of Science ®Google Scholar
• Villicev CM, Freitas FR, Aoki MS, et al. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. J Endocrinol. 2007;193:21–29.
   PubMed Web of Science ®Google Scholar
• Corp KGLS. Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers: ClinicalTrials.gov [Internet]. 2011. Available from: http://clinicaltrials.gov/ct2/show/record/NCT01444677?term=mb12066&rank =1.
   Google Scholar